TELA Bio, Inc. (TELA) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts TELA Hot Sheet
Join SI Premium – FREE
TELA Bio, Inc. (NASDAQ: TELA) reported Q2 EPS of ($0.20), $0.03 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $19.3 million versus the consensus estimate of $21.04 million.
For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investors push Seer, Inc. to disclose go-private timeline
- Sandisk targets mid-to-high teens revenue growth through FY2030
- SuperCom (SPCB) Tops Q3 EPS by 43c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
